<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02706093</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00106883</org_study_id>
    <nct_id>NCT02706093</nct_id>
  </id_info>
  <brief_title>Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults</brief_title>
  <acronym>HT</acronym>
  <official_title>Metabolic Adaptations in Response to High Intensity Interval Training in Obese Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objectives are to:&#xD;
&#xD;
        1. Assess mechanisms underlying HIIT-induced improvements in insulin resistance at the&#xD;
           whole-body, tissue, and cellular levels.&#xD;
&#xD;
        2. Systematically compare different HIIT regimens to help identify effective &quot;doses&quot; of&#xD;
           HIIT that may be optimal for improving metabolic health in obese adults.&#xD;
&#xD;
        3. Assess the ability/willingness of obese subjects to adhere to a long-term HIIT program.&#xD;
&#xD;
      Findings from these studies will greatly expand knowledge about the effects of HIIT on&#xD;
      metabolic health, and will provide valuable information for development of programs aimed at&#xD;
      maximizing key metabolic benefits of exercise.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If subjects are eligible for the study, they will be randomized into one of four different&#xD;
      exercise training groups. Before training (and twice after 3 months of training) subjects&#xD;
      will participate in a &quot;clinical study&quot; in which they will be required to stay overnight in&#xD;
      the hospital. During the clinical study, the research team will perform a series of metabolic&#xD;
      tests. Before and after the 3 months of training, the research team will assess subjects&#xD;
      &quot;free-living&quot; 24h blood sugar control using a Continuous Glucose Monitor (CGM). The research&#xD;
      team will measure several other relevant clinical markers (e.g., whole body and regional body&#xD;
      fat assessments [Dual Energy X-ray Absorptiometry (DEXA) and Magnetic Resonance Imager&#xD;
      (MRI)], hepatic lipid accumulation [MRI analysis], blood lipid profile, resting metabolic&#xD;
      rate, glycated hemoglobin [hemoglobin A1c]). After the first 3 months of training, adherence&#xD;
      to the subjects assigned training program will be tracked for the next 9 months (1 year of&#xD;
      training in total). One year after initiating a training program, subjects will be asked to&#xD;
      return to the clinic for a quick follow-up visit where the research team will complete some&#xD;
      standard clinical assessments (e.g., body weight, body composition, blood pressure, and a&#xD;
      blood sample).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">January 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Sensitivity</measure>
    <time_frame>Change from Baseline at 3 months</time_frame>
    <description>A hyperinsulinemic-euglycemic clamp will be used to assess peripheral insulin sensitivity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Continuous Glucose Monitoring</measure>
    <time_frame>Change from Baseline at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting Metabolic Rate</measure>
    <time_frame>baseline and 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Biopsy</measure>
    <time_frame>Change from Baseline at 3 months</time_frame>
    <description>To measure Mitochondrial Proteins</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adipose Tissue Biopsy</measure>
    <time_frame>Change from Baseline at 3 months</time_frame>
    <description>To measure cytokines</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>High Intensity Interval Training #1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate intensity continuous training</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Interval Training #2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Intensity Interval Training #3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Obese adults with impaired glucose tolerance will be randomized into one of four different exercise training groups for a 3 month exercise intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Interval Training #1</intervention_name>
    <description>(HIIT#1) 10 x 1 min. at ~90%HRmax - with low intensity warm-up, recovery, and cool down - total of 25 min/session .</description>
    <arm_group_label>High Intensity Interval Training #1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate intensity continuous training</intervention_name>
    <description>Moderate-intensity continuous training (MICT) = steady-state exercise at 60-70%HRmax for 45min. Representing a commonly prescribed exercise program.</description>
    <arm_group_label>Moderate intensity continuous training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Interval Training #2</intervention_name>
    <description>(HIIT #2) 5 x 1 min at 90%HRmax + 10 min steady-state exercise at 70%HRmax [25min; ~150kcals; 4d/wk]</description>
    <arm_group_label>High Intensity Interval Training #2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Intensity Interval Training #3</intervention_name>
    <description>(HIIT #3) 5 x 1 min at 90%HRmax [15min; ~90kcals; 4d/wk]</description>
    <arm_group_label>High Intensity Interval Training #3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18-40&#xD;
&#xD;
          -  Body Mass Index: 30-40 kg/m2&#xD;
&#xD;
          -  Waist circumference: 88-98cm for women and 100-110cm for men&#xD;
&#xD;
          -  Glucose intolerant (i.e., 2h glucose concentration during a screening oral glucose&#xD;
             tolerance test (OGTT)= 140-199mg/dl&#xD;
&#xD;
          -  No regularly planned exercise/physical activity&#xD;
&#xD;
          -  Women must have regularly occurring menses and must be premenopausal&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  EKG abnormalities as assessed by the cardiologist on the research team&#xD;
&#xD;
          -  Evidence/history of cardiovascular or metabolic disease&#xD;
&#xD;
          -  Medications known to affect lipid or glucose metabolism&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  Tobacco or e-cigarette use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Horowitz</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzette Howton</last_name>
    <phone>734-647-9850</phone>
    <email>suzetter@med.umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Suzette Howton</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48178</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzette Howton</last_name>
      <phone>734-647-9850</phone>
      <email>suzetter@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>jeff Horowitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2016</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Jeffrey F Horowitz</investigator_full_name>
    <investigator_title>Professor, Movement Science and Director, Substrate Metabolism Laboratory</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

